Jump to content

Glomerulopathy

From Wikipedia, the free encyclopedia
Glomerulopathy
SpecialtyUrologyEdit this on Wikidata

Glomerulopathyis a disease that impacts the glomeruli in thenephron,either inflammatory or noninflammatory.[1]Glomerulopathy includescollapsing glomerulopathy,glomerulocystic kidney disease,glomerulomegaly,membranous nephropathy,and tip lesion glomerulopathy.[2]

Collapsing glomerulopathy(CG) is a clinicopathologic entity that involveshypertrophyandhyperplasiaofpodocytesand segmentar or global collapse of theglomerulus.[3]

Glomerulocystic kidney diseaseis a rare form ofrenal cystdisease. Cortical microcysts, which are portrayed by cystic dilatation ofBowman's spaces,are its defining feature.[4]

Glomerulomegaly is defined by unusually largeglomeruli.[5]

Membranous nephropathy(MN) is an uncommonautoimmune conditionin whichautoantibodiesdirected primarily againstpodocyteantigens target theglomerulus,causing electron-denseimmune complexesto form, complement activation to occur, and severeproteinuria.[6]

The glomerular tip lesion (GTL) is a unique histopathologic lesion that appears in idiopathicnephrotic syndromepatients.[7]

See also

[edit]

References

[edit]
  1. ^"Monarch Initiative".monarchinitiative.org.RetrievedJanuary 7,2024.
  2. ^"Glomerulopathy (Concept Id: C0268731)".NCBI.October 31, 2023.RetrievedJanuary 7,2024.
  3. ^Cutrim, Érico Murilo Monteiro; Neves, Precil Diego Miranda de Meneses; Campos, Marcos Adriano Garcia; Wanderley, Davi Campos; Teixeira-Júnior, Antonio Augusto Lima; Muniz, Monique Pereira Rêgo; Ladchumananandasivam, Francisco Rasiah; Gomes, Orlando Vieira; Vasco, Rafael Fernandes Vanderlei; Brito, Dyego José de Araújo; Lages, Joyce Santos; Salgado-Filho, Natalino; Guedes, Felipe Leite; de Almeida, José Bruno; Magalhães, Marcelo; Araújo, Stanley de Almeida; Silva, Gyl Eanes Barros (March 3, 2022)."Collapsing Glomerulopathy: A Review by the Collapsing Brazilian Consortium".Frontiers in Medicine.9.Frontiers Media SA.doi:10.3389/fmed.2022.846173.ISSN2296-858X.PMC8927620.PMID35308512.
  4. ^Sahay, M.; Gowrishankar, S. (April 13, 2010)."Glomerulocystic disease".Clinical Kidney Journal.3(4). Oxford University Press (OUP): 349–350.doi:10.1093/ndtplus/sfq048.ISSN2048-8505.PMID25949428.
  5. ^Hughson, M. D.; Hoy, W. E.; Douglas-Denton, R. N.; Zimanyi, M. A.; Bertram, J. F. (November 29, 2010)."Towards a definition of glomerulomegaly: clinical-pathological and methodological considerations".Nephrology Dialysis Transplantation.26(7). Oxford University Press (OUP): 2202–2208.doi:10.1093/ndt/gfq688.ISSN0931-0509.PMC3164445.PMID21115671.
  6. ^Ronco, Pierre; Plaisier, Emmanuelle; Debiec, Hanna (February 5, 2021)."Advances in Membranous Nephropathy".Journal of Clinical Medicine.10(4). MDPI AG: 607.doi:10.3390/jcm10040607.ISSN2077-0383.
  7. ^Stokes, M. Barry; Markowitz, Glen S.; Lin, Julie; Valeri, Anthony M.; D'Agati, Vivette D. (2004)."Glomerular tip lesion: A distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum".Kidney International.65(5). Elsevier BV: 1690–1702.doi:10.1111/j.1523-1755.2004.00563.x.ISSN0085-2538.PMID15086908.

Further reading

[edit]
[edit]